News

Researchers at the Herbert Irving Comprehensive Cancer Center (HICCC) have recently completed an important new clinical trial demonstrating benefits of neoadjuvant combination immunotherapy plus chemotherapy in patients with non-small cell lung cancer (NSCLC).
Read More >
New Stomach Cancer Screening Center aids in prevention and improves early diagnosis of stomach cancer.
Read More >
Dr. Lawrence Schwartz reflects on ten years as chair of the department of radiology at NewYork-Presbyterian Hospital/Columbia University Irving Medical Center.
Read More >
A team of researchers at HICCC have uncovered important components of pancreatic cancer cell metabolism, hoping to identify therapeutic options to stop its growth.
Read More >
A team from Columbia University Irving Medical Center and NewYork-Presbyterian Hospital have been awarded a Translational Grant by the V Foundation for Cancer Research for their research into a new signaling pathway as a precision medicine approach to myelodysplasia (MDS) and acute myeloid leukemia (AML).
Read More >
Dr. Joseph Schwartz, MD, MPH, Professor of Pathology and Cell Biology, has been selected as the recipient of AABB’s 2019 Hemphill-Jordan Leadership Award, honoring him as a leader in the field of transfusion medicine and cellular therapy.
Read More >
The Prostate Cancer Foundation is supporting Dr. Dallos' ongoing innovative work to advance immunotherapies for prostate cancer patients.
Read More >

Pages